ArticleBMC ophthalmology2026
Complete blood count-derived inflammatory parameters in pediatric idiopathic uveitis.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric idiopathic uveitis is a potentially vision-threatening inflammatory condition with limited available laboratory biomarkers for disease monitoring. Complete blood count (CBC)-derived inflammatory parameters have emerged as inexpensive and accessible markers of systemic inflammation in various inflammatory diseases. This study aimed to investigate the potential role of CBC-derived inflammatory parameters in pediatric idiopathic uveitis and their association with disease activity.
methodsThis retrospective study included 40 children with idiopathic uveitis and 44 age-matched healthy controls. Comparisons were performed between patients with active uveitis and healthy controls, between patients in remission and healthy controls, and between the active and remission phases of the same patients. The same patients were evaluated during both active disease and remission periods. Patients with elevated C-reactive protein (CRP) levels, acute infection, systemic disease, or corticosteroid use at the time of blood sampling were excluded. Hematological parameters including white blood cell count (WBC), platelet count (PLT), mean platelet volume (MPV), red cell distribution width (RDW), neutrophil count, lymphocyte count, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and platelet-to-monocyte ratio (PMR) were analyzed.
resultsA total of 40 children with idiopathic uveitis, all of whom had normal CRP levels, and 44 age- and sex-matched healthy controls were included. Compared with healthy controls, patients during the active phase had significantly higher WBC, RDW, PLT, MPV, neutrophil count, lymphocyte count, and PMR values (all p < 0.05). During remission, RDW, PLT, MPV, and lymphocyte counts remained significantly elevated, whereas NLR values were lower than those of healthy controls, with borderline statistical significance (p = 0.049). In paired comparisons, WBC, PLT, neutrophil count, and PMR values were significantly higher during active disease than during remission, whereas MPV values were significantly higher during remission (all p < 0.05).
conclusionsCBC-derived inflammatory parameters, particularly RDW, platelet-related indices, and PMR, may reflect inflammatory activity in pediatric idiopathic uveitis despite normal CRP levels. Persistent alterations during remission may indicate ongoing subclinical inflammation. These inexpensive and readily available parameters may serve as complementary biomarkers in disease evaluation and follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.